MedTrace Logo

Tianjin Inpatient Acute Myocardial Infarction Registry

NCT03600259 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 13000

Last updated 2022-11-02

No results posted yet for this study

Summary

Acute myocardial infarction(AMI) is the most serious manifestation of coronary artery disease. AMI is characterized by high mortality, high disability, and high cost. However, multicenter research on AMI with large sample size in Tianjin or even China is limited. By including AMI in 36 hospitals,this multicenter study will capture the changes in epidemiological trends ,analyze the status of treatment in Tianjin, and explore the best treatment strategies.

Conditions

  • Myocardial Infarction, Acute

Sponsors & Collaborators

  • Tianjin Chest Hospital

    lead OTHER

Principal Investigators

  • Yin Liu, M.D · Tianjin Chest Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2023-01-01
Completion
2023-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600259 on ClinicalTrials.gov